Mariana González

Mariana González is a partner at Basham, Ringe y Correa, where she has established herself as a leading patent strategist in Mexico’s life sciences sector. She focuses on advanced patent prosecution, strategic patent drafting, regulatory exclusivity and linkage mechanisms for biotechnology, pharmaceutical, diagnostic and medical technology companies.

Her practice is distinguished by an integrated approach to patent and regulatory frameworks, enabling the development of commercially aligned intellectual property strategies in a complex jurisdiction. She advises on securing and managing patent protection for pharmaceutical and biotechnological inventions, often working with highly technical subject matter in biologics and advanced therapies.

González co-leads the firm’s life sciences patent practice advising Regeneron Pharmaceuticals on multiple complex patent applications in Mexico, including inventions relating to cardiac dysfunction, COVID-19 therapies and ovarian cancer treatments. 

In these matters, she has led claim restructuring strategies to navigate Mexico’s prohibition on patenting therapeutic methods, focusing instead on composition and functional claims to preserve innovation value within the legal framework.

She has also advised Bayer AG on regulatory data protection and patent term extension matters, including securing one of the few successful enforcements of clinical data protection in Mexico.

Her work includes advising Vella Bioscience on cannabinoid-based formulations for women’s health, where she developed patent strategies addressing therapeutic method exclusions under Mexican law, and structuring claims around formulation and delivery mechanisms.

González also provides strategic intellectual property advice to companies such as Eurofarma Laboratórios S.A. and Ceva Santé Animale, as well as to the University of Guadalajara, supporting technology transfer and the commercialisation of academic innovation through patent strategy and prosecution.

Beyond her client work, she serves as an invited expert advisor to the Mexican Association of Innovative Pharmaceutical Companies and is a member of the Advisory Council of the Mexican Patent Office (IMPI), contributing to policy-level discussions on intellectual property regulation and practice in Mexico.

She is president of Licensing Executives Society Mexico (LES México) and a member of the International Association for the Protection of Intellectual Property (AIPPI) Biotechnology Committee. She is also active in multiple international and national organisations, including AIPLA, LESI, AMPI, AmCham Mexico and INTA, reflecting her engagement across the global intellectual property community.

González is a frequent author and speaker at international forums, including AIPLA, Lex Mundi and various regional conferences, where she addresses issues relating to patent law, biotechnology innovation and regulatory frameworks.